The Clinical and Biomarker Association of Programmed Death Ligand 1 and its Spatial Heterogeneous Expression in Colorectal Cancer

Background: Programmed death ligand 1 (PD-L1) expression has been shown to predict benefit from anti-PD-1 treatment in several cancers. However, its predictive value in colorectal cancer seems limited. This study was aimed to explore the clinical and biomarker association of programmed death ligand...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cancer
Main Authors: Wei, Xiao-Li, Wu, Qi-Nian, Chen, Dong-liang, Zeng, Zhao-Lei, Lu, Jia-Bin, Liu, Ze-Xian, Ju, Huai-Qiang, Ren, Chao, Pan, Zhi-Zhong, Wang, Feng-Hua, Xu, Rui-Hua
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6277645/
https://ncbi.nlm.nih.gov/pubmed/30519336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.27735
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados